Cursos

← vista completa

Publicado el 1 de octubre de 2002 | http://doi.org/10.5867/medwave.2002.09.1344

Dislipidemias en el paciente diabético

Dyslipidemia in diabetic patients

Harold Lebovitz

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Harold Lebovitz

University of Medicine and Health Sciences, St. Kitts, Nueva York, Estados Unidos.

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Lebovitz H. Dyslipidemia in diabetic patients. Medwave 2002;2(09):e1344 doi: 10.5867/medwave.2002.09.1344

Envío 01/01/1970

Aceptación 01/01/1970

Publicación 01/10/2002

Métricas

Vistas en HTML

150

Descargas en PDF

15

Total

165

% Descargas en PDF

10%

Ver detalle

Notas

Referencias

  1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998 Jul 23;339(4):229-34. | CrossRef | PubMed
  2. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993 Jul;92(1):141-6. | CrossRef | PubMed
  3. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ,et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997 Jan 7;95(1):69-75. | PubMed
  4. Brown BG, Hillger L, Zhao XQ, Poulin D, Albers JJ. Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease. FATS Trial. Ann N Y Acad Sci 1995 Jan 17;748:407-17; discussion 417-8. Assmann G; Schulte H. Role of triglycerides in coronary artery disease: lessons from the Munster Study. Am J Cardiol 1992 Dec 14;70(19):10H-13H. | PubMed
  5. Assmann G; Schulte H. Role of triglycerides in coronary artery disease: lessons from the Munster Study. Am J Cardiol 1992 Dec 14;70(19):10H-13H. | CrossRef
  6. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001 Mar 24;357(9260):905-10. | CrossRef
  7. Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the 4S. Arch Intern Med 1999 Dec 13-27;159(22):2661-7. | CrossRef | PubMed
  8. Pfeffer MA, Sacks FM, Moyé LA, Brown L, Rouleau JL, Hartley LH,et al. Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. Am J Cardiol 1995 Sep 28;76(9):98C-106C. | CrossRef
  9. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ,et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial, JAMA 2001 Mar 28;285(12):1585-91. | CrossRef
  10. Collins R; Peto R; Armitage J. The MRC/BHF Heart Protection Study: preliminary results. Int J Clin Pract 2002 Jan-Feb;56(1):53-6. | PubMed